Adapted from Larsen et al. 2015. PLoS One. 10(2):e0118346. PMID: 25706943. Fig. Effect of dasatinib on the morphology of parental and resistant cells.
Representative pictures of parental (T47D/S2 and T47D/S5), tamoxifen (TR-1 and TR-1) and fulvestrant (182R-1 and 182R-2) resistant cell lines treated for five days with dasatinib (1 μM) or DMSO (control).